EUVIMEDEUVIMED entdecken
Open Access

Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis

Xiawei Dang iD, Lihong Zhang, Antonietta Franco, Gerald W Dorn Ii

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddac287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Xiawei Dang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Washington University School of Medicine, St. Louis MO USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, Muscular Dystrophy Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial involvement in neurodegenerative diseases is widespread and multifactorial. Targeting mitochondrial pathology is therefore of interest. The recent development of bioactive molecules that modulate mitochondrial dynamics (fusion, fission and motility) offers a new therapeutic approach for neurodegenerative diseases with either indirect or direct mitochondrial involvement. Here, we asked: (1) Can enhanced mitochondrial fusion and motility improve secondary mitochondrial pathology in superoxide dismutase1 (SOD1) mutant amyotrophic lateral sclerosis (ALS)? And: (2) What is the impact of enhancing mitochondria fitness on in vivo manifestations of SOD1 mutant ALS? We observed that small molecule mitofusin activators corrected mitochondrial fragmentation, depolarization and dysmotility in genetically diverse ALS patient reprogrammed motor neurons and fibroblasts, and in motor neurons, sensory neurons and fibroblasts from SOD1 G93A mice. Continuous, but not intermittent, pharmacologic mitofusin activation delayed phenotype progression and lethality in SOD1 G93A mice, reducing neuron loss and improving neuromuscular connectivity. Mechanistically, mitofusin activation increased mitochondrial motility, fitness and residency within neuromuscular synapses; reduced mitochondrial reactive oxygen species production; and diminished apoptosis in SOD1 mutant neurons. These benefits were accompanied by improved mitochondrial respiratory coupling, despite characteristic SOD1 mutant ALS-associated downregulation of mitochondrial respiratory complexes. Targeting mitochondrial dysdynamism is a promising approach to alleviate pathology caused by secondary mitochondrial dysfunction in some neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMiceAnimalsSuperoxide Dismutase-1SuperoxidesSuperoxide DismutaseMice, TransgenicMotor NeuronsMitochondriaDisease ProgressionDisease Models, Animal

Substanzen

Superoxide Dismutase-1SuperoxidesSuperoxide Dismutase

Autor:innen und Institutionen

  • Department of Internal Medicine, Washington University School of Medicine, St. Louis MO USA.
  • Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, Shaanxi 710061, China.

ORCID-Profile: Xiawei Dang

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS
  • Muscular Dystrophy Association
  • China Scholarship Council
  • National Institutes of Health

Zitieren

APA

Dang, X., Zhang, L., Franco, A., & Dorn Ii, G. W. (2023). Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac287

Vancouver

Dang X, Zhang L, Franco A, Dorn Ii GW. Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac287

BibTeX
@article{Dang2023,
  author = {Dang, Xiawei and Zhang, Lihong and Franco, Antonietta and Dorn Ii, Gerald W},
  title = {Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddac287}
}
Kostenlos starten →